Davidson Kempner Capital Management’s SAB Biotherapeutics SABS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-20,000	Closed	-$2.01M	–	594
2021 Q3	$2.01M	Buy	+20,000	New	+$2.01M	0.03%	277